RE:RE:RE:RE:RE:RE:Josh should really USE the Cormark 3 CENT target as evidenseAnchors are important. The 3 cent anchor provided by this key analyst may well play a strategic role is this man-made drama. I know that an anchor helps stops things from moving, like say a share price. It's really rather bizarre how Cormark has "handled" their Spectral Journey. Once they strategically placed their 11M or so shares at 70 cents ( MD&A claimed about 75% USA ), they went "negative" on their commentary. I remember them using a story about the "toxic" nature of Polymtxin B from a 1979 study. Our Toraymyxin (PMX) wasn't invented/approved until 1994, and the Polymmyxin B is embedded with the fibres of the PMX column making it completely safe. I wondered right away what the relevance of the analysts story was?? He also claimed a 3% inside ownership in that first report of the company and failed to properly make readers aware of the near 40% owned by Birch Hill and Toray.
Something doesn't add up here.....has a "Timinico light" feel when it comes to transperancy. The persistance of a clear "bullboard program" here for over a decade and a half is just added intrigue for me. I hope I do as well here as I did on Darnley Bay last year....did you know that our CEO used to be involved in Darnley Bay?? I hope he still owned shares in it, as it was the top performer on the Venture last year. I hope he does even 10% as well here as Darnley Bay did there. Good luck to all and "Anchors Away" as "they say"
Jorge
PS - Birch Hill needs to include us as an "investment partner" on their website almost 10 years now to update that little fact - "pittet patter, lets git at 'er